Search Results - "IDOATE, Miguel A"

Refine Results
  1. 1
  2. 2

    Prognostic Value of Residual Fluorescent Tissue in Glioblastoma Patients After Gross Total Resection in 5-Aminolevulinic Acid-Guided Surgery by Aldave, Guillermo, Tejada, Sonia, Pay, Eva, Marigil, Miguel, Bejarano, Bartolomé, Idoate, Miguel A., Díez-Valle, Ricardo

    Published in Neurosurgery (01-06-2013)
    “…Abstract BACKGROUND: There is evidence in the literature supporting that fluorescent tissue signal in fluorescence-guided surgery extends farther than tissue…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients by Grbesa, Ivana, Pajares, María J, Martínez-Terroba, Elena, Agorreta, Jackeline, Mikecin, Ana-Matea, Larráyoz, Marta, Idoate, Miguel A, Gall-Troselj, Koraljka, Pio, Ruben, Montuenga, Luis M

    Published in PloS one (27-04-2015)
    “…Sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2) are NAD+-dependent protein deacetylases involved in the regulation of key cancer-associated genes. In this study we…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    A Reassessment of the Barrier Effect of the Physis against Metaphyseal Osteosarcoma: A Comprehensive Pathological Study with Its Radiological and Clinical Follow-Up Correlations by Idoate, Miguel Á, Aquerreta, Jesús Dámaso, Lamo-Espinosa, José María, San-Julian, Mikel

    Published in Diagnostics (Basel) (09-02-2022)
    “…Osteosarcoma is a primary malignant bone tumor usually arising at the metaphysis of long bones, particularly around the knee. The physis has been regarded as a…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators by Rakha, Emad, Pajares, Maria J, Ilie, Marius, Pio, Ruben, Echeveste, Jose, Hughes, Elisha, Soomro, Irshad, Long, Elodie, Idoate, Miguel A, Wagner, Susanne, Lanchbury, Jerry S, Baldwin, David R, Hofman, Paul, Montuenga, Luis M

    Published in European journal of cancer (1990) (01-09-2015)
    “…Abstract Background Mortality in early stage, resectable lung cancer is sufficiently high to warrant consideration of post-surgical treatment. Novel markers to…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice by Eguren-Santamaria, Iñaki, Sanmamed, Miguel F, Goldberg, Sarah B, Kluger, Harriet M, Idoate, Miguel A, Lu, Benjamin Y, Corral, Jesús, Schalper, Kurt A, Herbst, Roy S, Gil-Bazo, Ignacio

    Published in Clinical cancer research (15-08-2020)
    “…Immune checkpoint inhibitors (ICI) have revolutionized the management of advanced non-small cell lung cancer (NSCLC). However, most pivotal phase III trials…”
    Get full text
    Journal Article
  14. 14

    Panobinostat Potentiates Temozolomide Effects and Reverses Epithelial–Mesenchymal Transition in Glioblastoma Cells by Urdiciain, Alejandro, Meléndez, Bárbara, Rey, Juan, Idoate, Miguel, Castresana, Javier

    Published in Epigenomes (01-03-2018)
    “…Glioblastoma is the most common form of glioma, as well as the most aggressive. Patients suffering from this disease have a very poor prognosis. Surgery,…”
    Get full text
    Journal Article
  15. 15

    A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma by Idoate Gastearena, Miguel A, López-Janeiro, Álvaro, Lecumberri Aznarez, Arturo, Arana-Iñiguez, Iñigo, Guillén-Grima, Francisco

    Published in Biomedicines (21-07-2022)
    “…Objectives: Immunostimulatory therapies using immune checkpoint blockers show clinical activity in a subset of glioblastoma (GBM) patients. Several inhibitory…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Phosphoinositide 3-kinase p85beta regulates invadopodium formation by Cariaga-Martínez, Ariel E, Cortés, Isabel, García, Esther, Pérez-García, Vicente, Pajares, María J, Idoate, Miguel A, Redondo-Muñóz, Javier, Antón, Inés M, Carrera, Ana C

    Published in Biology open (15-10-2014)
    “…The acquisition of invasiveness is characteristic of tumor progression. Numerous genetic changes are associated with metastasis, but the mechanism by which a…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less by Lozano, Maria D, Echeveste, José I, Abengozar, Marta, Mejías, Luis D, Idoate, Miguel A, Calvo, Alfonso, de Andrea, Carlos E

    “…- The rapid advances in targeted therapies in non-small cell lung cancer (NSCLC) make the optimization and implementation of cytology specimens for molecular…”
    Get full text
    Journal Article
  20. 20

    Tubastatin A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells by Urdiciain, Alejandro, Erausquin, Elena, Melendez, Barbara, Rey, Juan A, Idoate, Miguel A, Castresana, Javier S

    Published in International journal of oncology (01-05-2019)
    “…Glioblastoma or grade IV astrocytoma is the most common and lethal form of glioma. Current glioblastoma treatment strategies use surgery followed by…”
    Get full text
    Journal Article